Cyrus Biotechnology, Inc. · CIK 1641241
Cyrus Biotechnology, Inc.
Filings
2
Original notices
1
Amendments
1
Activity
Jul 16, 2025
through May 8, 2026
through May 8, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jul 16, 2025 · D | May 8, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $1,500,000 | $3,000,000 | $1,500,000 |
| Reported amount sold | $1,110,000 | $1,481,812 | $371,812 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001641241-25-000003 · Later SEC source: 0001641241-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $3,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $1,481,812
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001641241-26-000001D/A · May 8, 2026 · BiotechnologyOffering: $3,000,000Sold: $1,481,812
Compared with 0001641241-25-000003:
- Reported offering amount: $1,500,000 → $3,000,000
- Reported amount sold: $1,110,000 → $1,481,812
-
0001641241-25-000003D · Jul 16, 2025 · BiotechnologyOffering: $1,500,000Sold: $1,110,000